Drrx stock forecast.

DRRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. DURECT CORPORATION (DRRX) Compare. DURECT CORPORATION 3.29 ...Zacks Equity Research. Durect (DRRX) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.50 per share a year ago ...DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...DURECT has an Altman Z-Score of -16.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -16.45. Piotroski F-Score. 2. Detailed statistics for DURECT Corporation (DRRX) stock, including valuation metrics, financial numbers, share information and more.Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...

According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00.The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors can find some true

See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.DRRX Fair Price, Target Price, vs SPY, Historical gross margin, operating margin, net margin, ROE, cash flow, revenue and EPS. Financial, growth and cost analysis

The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median estimate represents a...Nov 8, 2023 · Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes. Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Get the latest TG Therapeutics Inc common stock (TGTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Broadly, the S&P’s financial sector is down 2% year-to-date, making it the worst-performing sector, followed by energy (down 8%), utilities (8%) and healthcare (3%). Pharmaceutical giant Pfizer ...

Durect (DRRX) delivered earnings and revenue surprises of -4% and 41.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...Apr 24, 2023 · Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ... GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.

View the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business.See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. May 11, 2023 · Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ... Trevena Inc. 0.58. +0.0051. +0.8873%. Get DURECT Corp (DRRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.What is the current Price Target and Forecast for DURECT (DRRX) DURECT (DRRX) (Delayed Data from NSDQ) $0.66 USD +0.01 (1.54%) Updated Nov 24, 2023 12:59 PM …

Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...DURECT Announces 1-for-10 Reverse Stock Split. CUPERTINO, Calif., Nov. 28, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX ), a biopharmaceutical company focused on developing epigenetic ...SNBR Stock Outlook. Sleep Number updated its outlook for the full year of 2023 in its latest earnings report as well. It now expects diluted EPS to be up to -70 cents while revenue will decrease ...Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...Durect (NASDAQ: DRRX) is one of my favorite cheap stocks to buy right now. It’s current price looks even more tempting given the company completed a 1-to-10 stock split late last year. Durect is ...DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants. CUPERTINO, Calif., Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a ...Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase …

DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...

for development and commercialization in other countries. ****CYTR (T/$10) scleroderma etal... DRRX (T/$3) Durect Corp... ... But don't expect its stock price to ...

Zacks Equity Research. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that it ...See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...DURECT Corporation (DRRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock DURECT Corporation | Nasdaq: DRRX | Nasdaq. 814c7.BI6jUPhZQxP2Us-zYE_8YwyJgJUUYh28OS76qNcwmk4.bt2SM58MJz61Cvb7TQevD0X7 …Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ... eCommerce double-digit growth in Q3 and share buyback of $18.6M. Raised 2023 Adjusted EBITDA range to $75M - $82M and Non-GAAP Net Income range to $7M - $12M.DIRTT Environmental Solutions Ltd. (DRTT) share price prediction for 2023, 2024, 2025, 2026 and 2027. DRTT one year forecast. DIRTT Environmental Solutions stock ...Find the latest Earnings Report Date for DURECT Corporation Common Stock (DRRX) at Nasdaq.com.

In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant.The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...Instagram:https://instagram. botox stockbreit stocktlt option chainbest gym insurance 3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or view top ... christies londonblfy stock NSD:DRRX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes etf scanner Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.However, it does not forecast the overall direction of its price. In a nutshell, if Durect's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Durect stock will not fluctuate a lot when Durect's options are near their ...Oct 15, 2020 · The Durect stock forecast is 1.3653368157524 USD for 2024 November 26, Tuesday; and 6.830 USD for 2028 November 26, Sunday with technical analysis. Durect (DRRX) stock price prediction is 1.3653368157524 USD.